Oncobit
PrivateLast Round
Early Funding
Nov 27, 2025
Total Funding Raised
$6.5M
Company Overview
Oncobit AG is a medtech company that has developed a scalable, data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers in liquid biopsies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncobit Comps
Public and private peers based on sector, stage, and business model.
Oncobit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 27, 2025 | ||||
| Early Funding | Nov 20, 2024 | ||||
| Seed | Apr 29, 2021 |
Key People
Founding team and executive leadership
Oncobit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avanteca Partners | Seed |
| ID SOLUTIONS | Early Funding |
| GF Group Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 27, 2025
Raised $2.36M with ID SOLUTIONS participating
- Nov 7, 2025
Monthly visitors increased 68% MoM to 2.1K.
Oncobit Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oncobit's valuation, stock price, and market status.
